Quantum BioPharma: Formerly FSD Pharma (Nasdaq:HUGE) – CSE
Quantum BioPharma, previously known as FSD Pharma, has recently filed a complaint in the United States courts against CIBC World Markets, RBC Dominion Securities, and others for alleged market manipulation of their share price. This has resulted in financial and emotional losses for both the company and its shareholders. To address this issue, the company has assembled legal teams to pursue recovery and damages. The company is seeking damages of over US$700M and is urging affected shareholders to come forward and share their specific losses.
Shareholders who have experienced losses due to shares sold in the relevant period are encouraged to provide details to Quantum BioPharma. This information will strengthen the case against those responsible for the financial harm caused. You can find the necessary form and details on the Quantum vs Banks page of the company’s website. Regular updates about the case will be posted there.
If you have experienced losses and wish to support the company in its pursuit of justice, you can provide your information via email or phone. Quantum BioPharma is dedicated to righting the alleged wrongs and ensuring that shareholders are compensated appropriately.
For those interested in learning more about the case and the company’s mission, you can review the public news releases dated October 21 and 22, 2024, or contact the company directly for further information.
Quantum BioPharma is a biopharmaceutical company focused on developing innovative solutions for neurodegenerative and metabolic disorders. Through its subsidiary, Lucid Psycheceuticals Inc., the company is working on drug candidates, including Lucid-MS, for the treatment of multiple sclerosis. Quantum BioPharma also has strategic investments in other areas, maintaining a diverse portfolio of assets.
In conclusion, Quantum BioPharma is actively pursuing justice for itself and its shareholders in response to the alleged market manipulation. Shareholders are encouraged to come forward and share their losses to support the company’s case against the perpetrators. For more information, visit the company’s website or contact them directly via email or phone.
